Helicobacter pylori and proton pump inhibitor therapy: One diagnostic method is enough?

Published: 4 November 2017
Author(s): Davide Giuseppe Ribaldone, Giorgio Maria Saracco, Rinaldo Pellicano
Section: Letter to the Editor

In a recent study Negovan et al. assessed the impact of pathological and clinical predisposing factors (histological findings, concomitant drug consumption, comorbidities, symptoms, social habits, Helicobacter pylori—H. pylori infection) on severe gastro-duodenal lesions in patients on long-term low-dose aspirin and proton pump inhibitors (PPI) treatment [1]. They enrolled patients with chronic low-dose aspirin and PPI therapy referred for an upper digestive endoscopy between September 2012 and December 2015.